Nymox Pharmaceutical Stock Price (NASDAQ:NYMX)

Add to My Stocks
$3.38 $0.02 (0.59%) NYMX stock closing price Jul 13, 2018 (Closing)
Prev Close* : $3.4
Market Cap:
$193.36M
Day Low: $3.35
52 Week Low: $3.00
Open: $3.35
Volume: -
Day High: $3.4
52 Week High: $4.60
Dividend:
0.00

Latest Stock Market News

Latest Articles

Nymox Pharmaceutical News - From Partners

NYMX Stockcharts

View NYMX PE ratio, PS ratio stocks charts and compare with peers.
NYMX Chart
Note: Compare Nymox Pharmaceutical stock price history with the index and industry peers.

Nymox Pharmaceutical Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
646.68
PB ratio (
price to book ratio
)
-233.74

Nymox Pharmaceutical Returns

ROE
(return on equity)
-

Nymox Pharmaceutical Financial Ratios

Asset Turnover
0.63
Receivables Turnover
11.54
Debt to Equity
-
Dividend Yield
0%

NYMX Industry Peers

Company Price Change (%)
Miragen Therap (MGEN)7.340.21 (2.95%)
Palatin Technologies (PTN)1.020 (0%)
Ovid Therapeutc (OVID)111.05 (10.55%)
Mustang Bio Inc (MBIO)7.490.05 (0.67%)
Baxalta (BXLT)46.020.18 (0.39%)
Regeneron Pharma (REGN)367.641.21 (0.33%)
Alexion Pharma (ALXN)135.871.58 (1.18%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Achillion Pharma (ACHN)3.140.21 (7.17%)
Momenta Pharma (MNTA)281.65 (6.26%)
Verastem (VSTM)8.50.44 (5.46%)
Pluristem Therapeutics (PSTI)1.30.05 (4%)
Uniquire (QURE)39.451.46 (3.84%)
Alder BioPharma (ALDR)19.250.7 (3.77%)
MediciNova (MNOV)8.810.27 (3.16%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jul 14, 2018
CompanyPriceChange (%)
Vericel Corp (VCEL)9.11.05 (10.34%)
Sorrento Therapeutics (SRNE)7.10.4 (5.33%)
Geron (GERN)3.620.19 (4.99%)
Dicerna Pharma (DRNA)12.50.64 (4.87%)
Amicus Therapeutics (FOLD)15.750.79 (4.78%)
Idera Pharma (IDRA)1.010.05 (4.72%)
MannKind (MNKD)1.70.08 (4.49%)
Top losers from Medical-Biomed-Genetics industry
* As of Jul 14, 2018

Nymox Pharmaceutical Financial Statements

income statement20172016201520142013
Net Sales or Revenues--2.76M2.94M3.35M
Net Income-13.42M-13.1M-17.88M-4.59M-4.9M
Total Operating Expense13.3M12.97M20.25M7.49M7.74M
View Nymox Pharmaceutical income statement
balance sheet20172016201520142013
Total Assets-2.05M-1.42M-
Total Liabilities2.23M2.69M3.46M5.6M7.02M
Shareholders Equity-1.25M-0.64M-2.75M-4.18M-6.05M
View Nymox Pharmaceutical balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities--0.58M-1.74M-2.3M-2.12M
Net Cash from (used by) Operating Activities-6.2M-4.5M-3.75M-5.51M-6.71M
Increase (Decrease) in Prop Plant And Equipment-----0.01M
View Nymox Pharmaceutical cash flow statement

Nymox Pharmaceutical Stock Message Board

Nymox Pharmaceutical stock price ended the last trading day at $3.38. Nymox Pharmaceutical market capitalization is $193.36M and it represents the total market value of NYMX stock. A value investor must look at the fundamentals of a stock, and perform Nymox Pharmaceutical valuation, even though in the short-term, sentiment and current breaking news might affect Nymox Pharmaceutical stock price.

For recognizing and analyzing the real performance of Nymox Pharmaceutical stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume number in Nymox Pharmaceutical stock quote data shows the number of shares traded. For Ex: 40,064 Nymox Pharmaceutical shares were traded as of last trading day, as seen from Nymox Pharmaceutical stock chart. Nymox Pharmaceutical paid 0.00 stock dividends to its shareholders during last quarter. One can observe stock price trends and check for volatility by checking Nymox Pharmaceutical stock price history.